unofficial english translation exhibit 10. 3 class ii new drug approval assignment agreement party a : harbin tianmu pharmaceuticals company limited party b : jilin tonghua yisheng pharmaceuticals company limited 1. name of the drug : nafarelin 1. 1. 2. indications : endometriosis ; prostatic cancer 2. indications : endometriosis ; prostatic cancer 2. indications : endometriosis ; prostatic cancer 2. 2. indications : endometriosis ; prostatic cancer indications : endometriosis ; prostatic cancer 3. closing of the assignment : based on the national pharmaceutical approval standard, the assignment shall be consummated when the phase 3 clinical trial is finished as evidenced by the new drug approval certificate. 3. closing of the assignment : based on the national pharmaceutical approval standard, the assignment shall be consummated when the phase 3 clinical trial is finished as evidenced by the new drug approval certificate. 3. closing of the assignment : based on the national pharmaceutical approval standard, the assignment shall be consummated when the phase 3 clinical trial is finished as evidenced by the new drug approval certificate. 3. 3. closing of the assignment : based on the national pharmaceutical approval standard, the assignment shall be consummated when the phase 3 clinical trial is finished as evidenced by the new drug approval certificate. closing of the assignment : based on the national pharmaceutical approval standard, the assignment shall be consummated when the phase 3 clinical trial is finished as evidenced by the new drug approval certificate. 4. specification : the drug e shall meet all the requirements of class ii new drug 4. specification : the drug e shall meet all the requirements of class ii new drug 4. specification : the drug e shall meet all the requirements of class ii new drug 4. 4. specification : the drug e shall meet all the requirements of class ii new drug specification : the drug e shall meet all the requirements of class ii new drug 5. total payment : rmb 33, 000, 000 5. total payment : rmb 33, 000, 000 5. total payment : rmb 33, 000, 000 5. 5. total payment : rmb 33, 000, 000 total payment : rmb 33, 000, 000 6. terms of payment : 33 % of the total amount ( rmb 11, 000, 000 ) shall be payable upon execution of this agreement. 33 % of the total amount rmb ( 11,